Clinical trials
Observational Gastrointestinal Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2014 | 1 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 4 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 10 |
| Completed | 5 |
| Recruiting | 3 |
| Not yet recruiting | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University | 2 |
| Peking University Cancer Hospital & Institute | 2 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Changhai Hospital | 1 |
| First Affiliated Hospital of Chongqing Medical University | 1 |
| Fudan University | 1 |
| Fujian Cancer Hospital | 1 |
| Nanfang Hospital, Southern Medical University | 1 |
| Qidong Gaitianli Medicines Co., Ltd | 1 |
| Renmin Hospital of Wuhan University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastrointestinal Neoplasms | 22 |
| Digestive System Neoplasms | 4 |
| Stomach Neoplasms | 4 |
| Colorectal Neoplasms | 3 |
| Gastrointestinal Diseases | 3 |
| Neoplasms | 3 |
| Anastomotic Leak | 2 |
| Digestive System Diseases | 2 |
| Adenoma | 1 |
| Adenomatous Polyps | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.